Tommy G. Thompson - 24 Mar 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Mar 2023
Net transactions value
-$788,175
Form type
4
Filing time
03 Apr 2023, 16:30:34 UTC
Previous filing
06 Mar 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $159,750 +2,500 +33% $63.90 10,100 24 Mar 2023 Direct F1
transaction UTHR Common Stock Disposed to Issuer $547,775 -2,500 -25% $219.11 7,600 24 Mar 2023 Direct F1
transaction UTHR Common Stock Options Exercise $159,750 +2,500 +33% $63.90 10,100 31 Mar 2023 Direct F1
transaction UTHR Common Stock Disposed to Issuer $559,900 -2,500 -25% $223.96 7,600 31 Mar 2023 Direct F1
holding UTHR Common Stock 5,800 24 Mar 2023 Family LLC
holding UTHR Common Stock 8,200 24 Mar 2023 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -2,500 -50% $0.000000 2,500 24 Mar 2023 Common Stock 2,500 $63.90 Direct F1
transaction UTHR Share Tracking Award Options Exercise $0 -2,500 -100% $0.000000* 0 31 Mar 2023 Common Stock 2,500 $63.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of share tracking awards set to expire 6/26/2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.